FMP
NASDAQ
0.65 USD
-0.059 (-9.13%)
Mr. Cuong Viet Do M.B.A.
Healthcare
Biotechnology
https://bioviepharma.com
NASDAQ
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to Bio...
0001580149
US09074F2074
09074F207
680 West Nye Lane
775 888 3162
US
18
Sep 18, 2020
0001580149
NASDAQ
Biotechnology
Healthcare
09074F207
US09074F2074
US
0.65
1.33
2.45M
35.5M
-
0.641-10.28
0.16
-
-
-
-
-0.55
-
https://bioviepharma.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.